← All organizations
Heart and Stroke Foundation of Canada
Academic/HospitalWebsite ↗
Also known as: Gerstein, Hertzel, MD | Heart and Stroke Foundation Manitoba | Heart and Stroke Foundation of Canada | Heart and Stroke Foundation of Canada - Canadian Partnership for Stroke Recovery | Heart and Stroke Foundation of Ontario
Highest phase reached
Phase 4
First clinical trial
Aug 1, 1998Last known activity
Jan 1, 2026
Timeline
1950s
- Jan 1, 1952
Heart and Stroke Foundation of Canada— Founded
Drugs by trial phase (61 distinct, 51 trials)
Phase 4 (9 own, 0 via acquisition)
Phase 3 (22 own, 0 via acquisition)
Phase 2 (16 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Other trials (11 own, 0 via acquisition)
Indications
Studied for
- Acute Coronary Syndrome
- Acute Kidney Injury
- Antiphospholipid Syndrome
- Apnea
- Arachnodactyly
- Atherosclerosis
- Atrial Fibrillation
- Brain Injuries
- Brain Injuries, Traumatic
- Cardiomyopathies
- Cardiomyopathy, Hypertrophic
- Cardiovascular Diseases
- Cerebral Hemorrhage
- Coronary Artery Disease
- Coronary Disease
- Diabetes Mellitus
- Diabetes Mellitus, Type 1
- Embolism
- Glucose Intolerance
- Glucose Metabolism Disorders
- Heart Arrest
- Heart Diseases
- Heart Failure
- Heart Valve Diseases
- Hematoma
- Hemorrhage
- Hypertension
- Hypertrophy
- Infarction
- Lupus Erythematosus, Systemic
- Marfan Syndrome
- Mental Disorders
- Metabolic Diseases
- Metabolic Syndrome
- Myocardial Infarction
- Myocardial Ischemia
- Osteoporosis
- Out-of-Hospital Cardiac Arrest
- Peripheral Arterial Disease
- Peripheral Vascular Diseases
- Pulmonary Embolism
- Renal Insufficiency
- Sleep Apnea, Obstructive
- Sleep Apnea Syndromes
- Syndrome
- Tachycardia
- Tachycardia, Ventricular
- Thromboembolism
- Thrombosis
- Vascular Diseases
- Venous Thromboembolism
- Venous Thrombosis
- Ventricular Fibrillation
- Wounds and Injuries
Recent trials (50)
- NCT07294950CollaboratorPhase 3Jan 1, 2026
- NCT07272902CollaboratorN/ADec 31, 2025
- NCT06601465CollaboratorPhase 2Nov 30, 2024
- NCT06588946CollaboratorN/ANov 30, 2024
- NCT06424860CollaboratorPhase 1Oct 1, 2024
- NCT06287619CollaboratorPhase 2Sep 30, 2024
- NCT06182839CollaboratorPhase 2Mar 30, 2024
- NCT05868109CollaboratorPhase 2Aug 31, 2022
- NCT04021550CollaboratorEarly Phase 1Sep 30, 2019
- NCT03508895CollaboratorN/AApr 30, 2018
- NCT03335839CollaboratorPhase 3Apr 1, 2018
- NCT02518828CollaboratorN/AJan 31, 2017
- NCT02830360CollaboratorPhase 4Oct 1, 2016
- NCT01990768CollaboratorPhase 2May 1, 2015
- NCT02117661CollaboratorPhase 2Jan 1, 2015
Details
- Founded
- Ottawa, CA Jan 1, 1952
- Last known activity
- Jan 1, 2026